Meet your early-stage partner​

Put your parenteral product on the path to clinical success

In the early phases of drug development, choosing the right CDMO partner is key. Vetter provides comprehensive resources for early phase clinical manufacturing.

vial inspected by worker for clinical trials
Join one of our free 30-minute webcasts

Speed Meets Expertise: Inside Vetter’s Clinical Drug Product Manufacturing Sites in the US and EU

October 9 | 9:00 – 9:30 AM EST | 3:00 – 3:30 PM CET

Register for session 1

October 9 | 9:00 – 9:30 AM PST | 12:00 – 12:30 PM EST

Register for session 2

We're a trusted source for clinical supplies

Molecule icon
API protection

We handle your valuable drug substance with regulatory and quality safeguards at every step.

vial and syringe icon
Customized outputs

We tailor clinical production to your needs, from a few hundred Phase 1 units to large Phase 3 batches.

Time to market icon
Accelerated time-to-market

Our services can help expedite your product’s path to market – and to patients who need your clinical breakthrough.

Experience with complex molecules

We support a wide range of substance classes, including oligonucelotides, monoclonal antibodies, fusion proteins, peptide hormones, and coagulation factors.

Stay focused on your molecule. We'll take care of the rest.

With Vetter as your partner, our skilled project managers will guide you through key fill-and-finish processes across your product’s development cycle. Our clinical manufacturing services include:

  • Material preparation
  • Analytical testing
  • Compounding
  • Filtration
  • Technical and clinical batches
  • Lyophilization
  • Sampling
  • Terminal sterilization
  • Visual inspection
  • Storage and shipping
  • Stability testing

See where we fill your clinical supplies

VDS-C: Vetter Developmen Service Chicago

US: Vetter Development Service Chicago

Located in the Illinois Science & Technology Park, the clinical site offers 54,000 ft2 of lab space, two filling lines for pre-sterilized syringes as well as liquid and lyophilized vials, storage, visual inspection and officses. The site went operational in 2011 with currently 110+ manufacturing specialists.

VDS-R: Vetter Development Service Rankweil

EU: Vetter Development Service Rankweil

This site in Austria (only 100km from Vetter’s commerhial hub)) offers 80,000 ft2 of dedicaed early phase production space with one flling line for liquid and lyophilized vials, lab space, storage, visual inspection and offices. The site is online since 2021 with currently 85+ manufacturing specialists.

Facts & history

Facts & figures

80 %
of our active customer projects involve complex biologics
40 +
new projects are onboarded annually
40 %
of customers with clinical projects have <50 employees
35 %
of our clinical customers fill more than one product with us
280 +
successful customer audits at our Chicago and Rankweil sites
1300 +
customer fills with no failures

What our customers have to say

  • Logo Agenus

    Vetter’s expertise and uncompromising quality have contributed to our success, even under our aggressive timelines. It has been a pleasure working with the Vetter Teams in Chicago and Germany.

    Ron Tetreault, Director of CMC, Agenus, Inc.

  • Customer Feedback moonlake

    We are excited to work with such a high quality and reliable partner. With Vetter’s world-class support, we can further strengthen the supply chain for our novel drug sonelokimab from filling of syringes and subsequent assembly into an autoinjector combination device and packaging.

    Oliver Daltrop, Chief Technical Officer, MoonLake

Contact Us

Don’t know how to get started with your first batch?

Reach out to Paul Earnshaw, Director Global Clinical Business Development at Vetter. He has extensive experience with fill and finish services for biotech and pharmaceutical companies, and will be happy to share how we can support you.

Reach out to Paul